ES2061734T3 - Estructura farmaceutica con substancias activas unidas a portadores proteinicos. - Google Patents

Estructura farmaceutica con substancias activas unidas a portadores proteinicos.

Info

Publication number
ES2061734T3
ES2061734T3 ES88890212T ES88890212T ES2061734T3 ES 2061734 T3 ES2061734 T3 ES 2061734T3 ES 88890212 T ES88890212 T ES 88890212T ES 88890212 T ES88890212 T ES 88890212T ES 2061734 T3 ES2061734 T3 ES 2061734T3
Authority
ES
Spain
Prior art keywords
proteinic
carriers
active substances
protein
pharmaceutical structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88890212T
Other languages
English (en)
Inventor
Uwe B Prof Dipl-Ing Dr Sleytr
Wolfgang Dipl-Ing Dr Mundt
Paul Dipl-Ing Dr Messner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2061734T3 publication Critical patent/ES2061734T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE TRATA DE UN ESTRUCTURA FARMACEUTICA EN LA QUE ESTAN UNIDOS HAPTENOS Y/O SUSTANCIAS INMUNOGENAS O ESTIMULADORAS INMUNES A UN PORTADORPROTEICO. PARA CONSEGUIR LUGARES DE UNION EXACTAMENTE DEFINIBLES DE LOS HAPTENOS Y/O SUSTANCIAS INMUNOGENAS O ESTIMULADORAS INMUNES EN LOS PORTADORES PROTEICOS SE FORMAN ESTOS ULTIMOS CON MOLECULAS DE PROTEINA O MOLECULAS CONTENEDORAS DE PROTEINAS UNIDAS COVALENTEMENTE O SITUADAS JUNTAS MEDIANTE CRISTALINA O PARACRISTALINA. (FIG.1): ------- ALBUMINA DE SUERO VACUNO UNIDA A CAPAS S NO OXIDADAS (ABSORCION NO ESPECIFICA); - - - - ALBUMINA DE SUERO VACUNO UNIDA A CAPAS S OXIDADAS (FORMACION DE BASES DE SCHIFF CON E - AMINOGRUPOS DE RESTODE LISILO.
ES88890212T 1987-08-21 1988-08-19 Estructura farmaceutica con substancias activas unidas a portadores proteinicos. Expired - Lifetime ES2061734T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873727987 DE3727987A1 (de) 1987-08-21 1987-08-21 Pharmazeutische struktur

Publications (1)

Publication Number Publication Date
ES2061734T3 true ES2061734T3 (es) 1994-12-16

Family

ID=6334228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88890212T Expired - Lifetime ES2061734T3 (es) 1987-08-21 1988-08-19 Estructura farmaceutica con substancias activas unidas a portadores proteinicos.

Country Status (7)

Country Link
EP (1) EP0306473B1 (es)
JP (1) JP2708487B2 (es)
AT (1) ATE97323T1 (es)
AU (1) AU627154B2 (es)
DE (2) DE3727987A1 (es)
ES (1) ES2061734T3 (es)
IL (1) IL87390A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012069683A1 (es) * 2010-11-23 2012-05-31 Consejo Superior De Investigaciones Científicas (Csic) Haptenos e inmunoreactivos y su uso en la obtención de anticuerpos de familia e inmunoensayos para quinolonas

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7249491A (en) * 1990-03-02 1991-09-18 Alberta Research Council Inc. Improved immunogenic compositions
DE4115038A1 (de) * 1991-05-08 1992-11-12 Genentech Inc Neue konjugate, bestehend aus einem glykoprotein und einer nukleinsaeure-bindenden substanz
AU2005316041B2 (en) * 2004-12-14 2010-06-24 Alk Abello A/S Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6789910D0 (pt) * 1966-10-17 1973-05-17 Fmc Corp Processo para preparar comestiveis contendo colagenio microcristalino
US4166767A (en) * 1976-03-25 1979-09-04 Dainippon Pharmaceutical Co., Ltd. Insolubilized antibody
DE2636206C3 (de) * 1976-08-12 1981-06-04 C.H. Boehringer Sohn, 6507 Ingelheim Trägerfixierte Enzyme sowie ihre Herstellung und Anwendung
JPS5428813A (en) * 1977-08-09 1979-03-03 Yuuichi Yamamura Solid preparation containing cell membrane extract substance used as suspension when using same
US4411832A (en) * 1979-11-26 1983-10-25 Pedro Cuatrecasas Polysaccharide matrices comprising macromolecular spacer arms for use as adsorbents in affinity chromatography techniques
DE3167679D1 (en) * 1980-03-31 1985-01-24 Inst Int Pathologie Cellulaire Pharmaceutical forms, their preparation and compositions containing the same
US4465668A (en) * 1981-02-27 1984-08-14 Asahi Kasei Kogyo Kabushiki Kaisha Method for improving intestinal absorption of cephalosporin derivatives
DE3224788A1 (de) * 1981-07-17 1983-02-03 South African Inventions Development Corp., Scientia, Pretoria,Transvaal Traegergebundenes immunogenes material
AT373278B (de) * 1982-03-23 1984-01-10 Inst Po Mikrobiologia Verfahren zur immobilisierung von mikrobenzellen mit einer glucose-isomerase-aktivitaet
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4486344A (en) * 1983-03-28 1984-12-04 Miles Laboratories, Inc. Urea-linked immunogens, antibodies, and preparative method
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012069683A1 (es) * 2010-11-23 2012-05-31 Consejo Superior De Investigaciones Científicas (Csic) Haptenos e inmunoreactivos y su uso en la obtención de anticuerpos de familia e inmunoensayos para quinolonas
ES2383857A1 (es) * 2010-11-23 2012-06-27 Consejo Superior De Investigaciones Científicas (Csic) Haptenos e inmunoreactivos y su uso en la obtención de anticuerpos de familia e inmunoensayos para quinolonas
US10150736B2 (en) 2010-11-23 2018-12-11 Consejo Superior De Investigaciones Cientificas (Csic) Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones

Also Published As

Publication number Publication date
AU2142588A (en) 1989-03-16
JPH01207245A (ja) 1989-08-21
DE3885680D1 (de) 1993-12-23
DE3727987A1 (de) 1989-03-02
ATE97323T1 (de) 1993-12-15
EP0306473B1 (de) 1993-11-18
EP0306473A1 (de) 1989-03-08
JP2708487B2 (ja) 1998-02-04
IL87390A (en) 1993-07-08
IL87390A0 (en) 1989-01-31
AU627154B2 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
DE3852163D1 (de) An Dianhydriden gebundene Polymerstabilisatoren.
FI891896L (fi) Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa
DE3785485D1 (de) Elektroden mit immobilisierten enzymen.
DE3854174D1 (de) Kraftstoffeinspritzventil.
NO871409L (no) Fusjonsprotein.
DE3780301D1 (de) Geraet zur sequenzanalyse von basen.
IT1088809B (it) Procedimento per l'immobilizzazione di proteine
DE3865628D1 (de) Einrichtung zur zuechtung von kristallen.
FI882283L (fi) Proteiner med tnf-verkan.
FI861424A7 (fi) Parannettu menetelmä metallitioneiinin konjugoimiseksi biologisesti aktiivisiin molekyyleihin.
FI875324L (fi) Hybridproteiner.
DE3761072D1 (de) Blendenanordnung zur optoelektronischen abtastung von vorlagen.
DE3882607D1 (de) Multiblatt-membranmodul.
ES2061734T3 (es) Estructura farmaceutica con substancias activas unidas a portadores proteinicos.
FI884240A0 (fi) Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi
DE68914571D1 (de) Elektroeinsetzung von Proteinen in Membranen von Tierzellen.
DE69619257D1 (de) Die konjugation von liganden an immobilisierte proteine in einem organischen lösungsmittel
DE3788690D1 (de) Handgerät zur Abtastung von Dokumenten.
NO873216L (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
DE58904672D1 (de) Verfahren zur herstellung einer festphasenmatrix.
ATE133993T1 (de) Protein-antikrebsmittel
DE3888437D1 (de) Immobilisierte Antikörper.
DE3768040D1 (de) Geraet zur reproduktion von dokumenten.
ES2074179T3 (es) Haptenos marcados mejorados, procedimiento para su preparacion, asi como empleo de estos haptenos marcados en inmunoensayos.
IT8722051A0 (it) Miglioramenti nelle cinghie dentate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 306473

Country of ref document: ES